Have You Developed Alopecia or Hair Loss
after Taking Taxotere?
While chemotherapy patients often lose their hair, the loss is usually temporary with hair growing back within months of completion of their treatments. However, the hair loss associated with Taxotere may be permanent and irreversible. Women may find this hair loss particularly distressing and disfiguring. Experts suggest that hair loss can be devastating for some patients and negatively impact their quality of life.
Almost three million U.S. women have been diagnosed with breast cancer, and thousands more are diagnosed every year. About three-quarters of these breast cancer patients received Taxotere. Our firm is currently investigating claims that Sanofi-Aventis engaged in illegal activities to increase sales of the chemotherapy medication while hiding the side effects from the public. In fact, some patients are alleging that the company knew in the 1990s that the drug carries an increased risk of permanent hair loss.
- Head hair
- Pubic hair
- Beard and mustache hair for men
- Decreased vision
FREE Case Evaluation
How can we help you? If you would like to learn more about your legal rights and options, please call 888-611-7830 or complete the form below.
.(100% Privacy Guaranteed )
A breast cancer survivor filed a lawsuit in 2016 alleging Sanofi-Aventis engaged in fraudulent marketing tactics to increase sales and accused the company of increasing revenues at the expense of cancer victims who were unaware of the serious side effects of the drug, including increased toxicity and permanent hair loss. The plaintiff claims that she would not have used Taxotere if she knew of the side effects.
FDA Taxotere Warning and Safety Labeling Changes
- Acute pulmonary edema
- Acute pulmonary distress
- Interstitial lung disease/pneumonia
- Respiratory failure
- Pulmonary Fibrosis
- Eye disorders including:
- Cystoid macular edema
- Decreased vision